The impact of blended finance in support of medical research
This event will focus on blended finance across the spectrum of medical research, how collaboration among organisations using diverse investment initiatives is helping to develop a new generation of entrepreneurial scientists.
Speakers at the event will include:
- Professor Sir Mark Caulfield who has been instrumental in delivering the world-leading 100,000 Genomes Project, which hit its target of sequencing 100,000 whole genomes in 2018 and has already delivered life-changing results
- Richard Ross, a philanthropist who will discuss funding basic science that generates further funding leading to major advances in medical treatment. He supports researchers who think ‘out of the box’ with a good chance of success
- James Carleton, a lawyer who will share his experience in advising clients in their philanthropy, with a focus on medical research
The discussion will be facilitated by award-winning writer and broadcaster Vivienne Parry. A scientist by training, she hosts medical programmes for BBC Radio 4 and writes widely on health. She presented on Tomorrow’s World and Panorama, and was awarded the OBE in 2011 for “services to the public understanding of science”.
Chair: Vivienne Parry OBE, Science Writer and Broadcaster, Head of Engagement, Genomics England; Board Member, UK Research and Innovation
Discussion: Professor Sir Mark Caulfield FMedSci, Chief Executive, Genomics England and Co-Director, William Harvey Research Institute; Professor of Clinical Pharmacology at Queen Mary University of London
Richard Ross, Chairman, Rosetrees Trust
James Carleton, Partner, Farrer & Co.